Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Taylor

Showing results (191-200 of 206) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapyW S Dalton, T M Grogan, P S Meltzer, et al.
Investigational New Drugs|January 1, 1990
A phase I and pharmacokinetic study of intravenous vinzolidineC W Taylor, S E Salmon, W G Satterlee, et al.
Cancer Research|December 15, 1996
Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cellsA Gallegos, J R Gasdaska, C W Taylor, et al.
British Journal of Cancer|June 11, 1999
Enhancement of chemotherapy by manipulation of tumour pHN Raghunand, X He, R van Sluis, et al.
Cancer Research|February 1, 1980
Tumorigenic activity of benzo(e)pyrene derivatives on mouse skin and in newborn miceM K Buening, W Levin, A W Wood, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 8, 2019
International Variation in Criteria for Internal Mammary Chain RadiotherapyF K Duane, P McGale, S Teoh, et al.
Investigational New Drugs|November 1, 1991
Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three casesF V Fossella, S M Lippman, D E Seitz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Human tumor models in the severe combined immune deficient (scid) mouseG D Paine-Murrieta, C W Taylor, R A Curtis, et al.
Journal of the National Cancer Institute|December 2, 1992
Antitumor activity and clinical pharmacology of sulofenur in ovarian cancerC W Taylor, D S Alberts, Y M Peng, et al.
Molecular Pharmacology|January 12, 1999
Acyclophostin: a ribose-modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacyM D Beecroft, J S Marchant, A M Riley, et al.
Pageof 21

Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapyW S Dalton, T M Grogan, P S Meltzer, et al.
Investigational New Drugs|January 1, 1990
A phase I and pharmacokinetic study of intravenous vinzolidineC W Taylor, S E Salmon, W G Satterlee, et al.
Cancer Research|December 15, 1996
Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cellsA Gallegos, J R Gasdaska, C W Taylor, et al.
British Journal of Cancer|June 11, 1999
Enhancement of chemotherapy by manipulation of tumour pHN Raghunand, X He, R van Sluis, et al.
Cancer Research|February 1, 1980
Tumorigenic activity of benzo(e)pyrene derivatives on mouse skin and in newborn miceM K Buening, W Levin, A W Wood, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 8, 2019
International Variation in Criteria for Internal Mammary Chain RadiotherapyF K Duane, P McGale, S Teoh, et al.
Investigational New Drugs|November 1, 1991
Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three casesF V Fossella, S M Lippman, D E Seitz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Human tumor models in the severe combined immune deficient (scid) mouseG D Paine-Murrieta, C W Taylor, R A Curtis, et al.
Journal of the National Cancer Institute|December 2, 1992
Antitumor activity and clinical pharmacology of sulofenur in ovarian cancerC W Taylor, D S Alberts, Y M Peng, et al.
Molecular Pharmacology|January 12, 1999
Acyclophostin: a ribose-modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacyM D Beecroft, J S Marchant, A M Riley, et al.
Pageof 21